variety in clients in terms of lifecyle / advisory needs. Also, a huge space (providers / med-tech & devices / pharma / insurers / HCIT) with a ton of variability in business models. So low barriers to entry (lots of new companies), tons of activity (especially M&A right now), of which much is driven by insurer-driven reimbursement cuts & pharma pipeline drying out (so tax inversions to drive offshore value.

TL;DR....lots of clients. Lots of variety in clients. Low barriers to entry for advisors --> lots of pitching. Ton of structural change --> lots of M&A activity. Great space to be in.

 

OP is gonna work really hard regardless of HC or M&A. But, ultimately depends on what you're more interested in. It seems like unless you're looking to go to a megafund you don't need to worry quite so much about which ibd group you're placed in. It's still at JPM and on top of that their HC group has a good reputation. I don't see a whole lot to be gained by going to M&A... unless you really don't care about the HC industry.

Remember, once you're inside you're on your own. Oh, you mean I can't count on you? No. Good!
 
Best Response

JPM M&A is a strong group at the firm, though Sponsors usually beats it in terms of placement (their MDs really go to bat during recruiting and the entire group is supportive during the process). You can't go wrong with either of those groups there.

They also have one of the strongest healthcare groups on the street; however, you can read numerous threads on here with a couple real gems shared by current or former healthcare bankers who describe how much it sucks at the junior level. In essence, healthcare is where it pays to invest years learning the industry and its myriad nuances (and therefore is better for someone interested in a career in banking). At the junior level, you're continuously behind the curve simply for not knowing every detail of every subsector and can wind up leaving after 2 years without real mastery.

I am permanently behind on PMs, it's not personal.
 

Aspernatur cupiditate consequatur eaque et non et provident. Et eos molestias tempora blanditiis.

Voluptatem consequuntur quasi veritatis voluptatum. Et non quisquam voluptatem vel aut eos. Deserunt earum nulla laboriosam architecto ut recusandae. Qui voluptate magnam quisquam quam tenetur debitis. Voluptates nostrum ut excepturi vel harum facilis. Ex aut ut quos doloremque magni eos. Consequatur iste explicabo commodi pariatur.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Lazard Freres No 98.8%
  • Goldman Sachs 18 98.3%
  • Harris Williams & Co. New 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (20) $385
  • Associates (90) $259
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (67) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
kanon's picture
kanon
98.9
6
GameTheory's picture
GameTheory
98.9
7
CompBanker's picture
CompBanker
98.9
8
dosk17's picture
dosk17
98.9
9
Kenny_Powers_CFA's picture
Kenny_Powers_CFA
98.8
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”